- Home
- CSBR vs STHO Comparison
CSBR vs STHO Comparison
Compare CSBR & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- STHO
- Stock Information
- Founded
- CSBR 1985
- STHO N/A
- Country
- CSBR United States
- STHO United States
- Employees
- CSBR N/A
- STHO N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- STHO Real Estate
- Sector
- CSBR Health Care
- STHO Real Estate
- Exchange
- CSBR Nasdaq
- STHO Nasdaq
- Market Cap
- CSBR 123.2M
- STHO 112.7M
- IPO Year
- CSBR 1986
- STHO N/A
- Fundamental
- Price
- CSBR $6.42
- STHO $8.21
- Analyst Decision
- CSBR Strong Buy
- STHO
- Analyst Count
- CSBR 1
- STHO 0
- Target Price
- CSBR $12.00
- STHO N/A
- AVG Volume (30 Days)
- CSBR 40.7K
- STHO 43.8K
- Earning Date
- CSBR 09-15-2025
- STHO 11-04-2025
- Dividend Yield
- CSBR N/A
- STHO N/A
- EPS Growth
- CSBR N/A
- STHO N/A
- EPS
- CSBR 0.21
- STHO N/A
- Revenue
- CSBR $56,878,000.00
- STHO $113,989,000.00
- Revenue This Year
- CSBR $9.30
- STHO N/A
- Revenue Next Year
- CSBR $31.17
- STHO N/A
- P/E Ratio
- CSBR $29.53
- STHO N/A
- Revenue Growth
- CSBR 10.11
- STHO N/A
- 52 Week Low
- CSBR $3.75
- STHO $6.06
- 52 Week High
- CSBR $11.99
- STHO $13.50
- Technical
- Relative Strength Index (RSI)
- CSBR 46.30
- STHO 42.93
- Support Level
- CSBR $6.27
- STHO $8.01
- Resistance Level
- CSBR $6.90
- STHO $8.39
- Average True Range (ATR)
- CSBR 0.29
- STHO 0.27
- MACD
- CSBR -0.02
- STHO -0.08
- Stochastic Oscillator
- CSBR 23.37
- STHO 26.24
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.